These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. HTLV-III in the tears of AIDS patients. Fujikawa LS; Salahuddin SZ; Ablashi D; Palestine AG; Masur H; Nussenblatt RB; Gallo RC Ophthalmology; 1986 Dec; 93(12):1479-81. PubMed ID: 3643502 [TBL] [Abstract][Full Text] [Related]
4. Isolation of human immune deficiency virus from African AIDS patients and from persons without AIDS or IgG antibody to human immune deficiency virus. McCormick JB; Krebs JW; Mitchell SW; Feorino PM; Getchell JP; Odio W; Kapita B; Quinn TC; Piot P Am J Trop Med Hyg; 1987 Jan; 36(1):102-6. PubMed ID: 2949638 [TBL] [Abstract][Full Text] [Related]
5. The origins of HIV-1 and HTLV-4/HIV-2. Kanki PJ; Hopper JR; Essex M Ann N Y Acad Sci; 1987; 511():370-5. PubMed ID: 2894192 [TBL] [Abstract][Full Text] [Related]
6. Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. Salahuddin SZ; Markham PD; Popovic M; Sarngadharan MG; Orndorff S; Fladagar A; Patel A; Gold J; Gallo RC Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5530-4. PubMed ID: 2991931 [TBL] [Abstract][Full Text] [Related]
8. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings. Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682 [TBL] [Abstract][Full Text] [Related]
9. Recovery of HIV-related retroviruses from Italian patients with AIDS or AIDS-related complex and from asymptomatic at-risk individuals. Rossi GB; Verani P; Macchi B; Federico M; Orecchia A; Nicoletti L; Buttò S; Lazzarin A; Mariani G; Ippolito G Ann N Y Acad Sci; 1987; 511():390-400. PubMed ID: 3439718 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndrome. Blattner WA; Biggar RJ; Weiss SH; Melbye M; Goedert JJ Ann Intern Med; 1985 Nov; 103(5):665-70. PubMed ID: 2996397 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan. Ikegami N AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640 [TBL] [Abstract][Full Text] [Related]
12. Australian hemophiliac recipients of voluntary donor blood products longitudinally evaluated for AIDS. A clinical and laboratory study, 1983-1986. Garsia RJ; Gatenby PA; Basten A; Kenny DF; Gallagher KJ; Rickard KA; Gust ID; Maskill W Aust N Z J Med; 1987 Aug; 17(4):371-8. PubMed ID: 2963611 [TBL] [Abstract][Full Text] [Related]
13. AIDS in Haitian-Americans: a reassessment. Frank E; Weiss SH; Compas JC; Bienstock J; Weber J; Bodner A; Landesman SH Cancer Res; 1985 Sep; 45(9 Suppl):4619s-4620s. PubMed ID: 2990695 [TBL] [Abstract][Full Text] [Related]
14. Epidemiological trends of AIDS in the United States. Curran JW; Morgan WM; Starcher ET; Hardy AM; Jaffe HW Cancer Res; 1985 Sep; 45(9 Suppl):4602s-4604s. PubMed ID: 2990692 [TBL] [Abstract][Full Text] [Related]
15. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Safai B; Sarngadharan MG; Groopman JE; Arnett K; Popovic M; Sliski A; Schüpbach J; Gallo RC Lancet; 1984 Jun; 1(8392):1438-40. PubMed ID: 6145881 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain. Cheingsong-Popov R; Weiss RA; Dalgleish A; Tedder RS; Shanson DC; Jeffries DJ; Ferns RB; Briggs EM; Weller IV; Mitton S Lancet; 1984 Sep; 2(8401):477-80. PubMed ID: 6147546 [TBL] [Abstract][Full Text] [Related]
17. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells. Schechter MT; Boyko WJ; Jeffries E; Willoughby B; Nitz R; Constance P; Weaver M; Wiggs B; O'Shaughnessy M Can Med Assoc J; 1985 Aug; 133(4):286-92. PubMed ID: 2990652 [TBL] [Abstract][Full Text] [Related]
18. Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Goedert JJ; Biggar RJ; Weiss SH; Eyster ME; Melbye M; Wilson S; Ginzburg HM; Grossman RJ; DiGioia RA; Sanchez WC Science; 1986 Feb; 231(4741):992-5. PubMed ID: 3003917 [TBL] [Abstract][Full Text] [Related]
19. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia. Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375 [TBL] [Abstract][Full Text] [Related]
20. Antibody to human lymphotropic virus type III: immunologic status of homosexual contacts of patients with the acquired immunodeficiency syndrome and the acquired immunodeficiency-related complex. Goldsmith JM; Kalish SB; Ostrow DG; Britz J; Chmiel JS; Wallemark CB; Phair JP Sex Transm Dis; 1987; 14(1):44-7. PubMed ID: 2951878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]